A Danish biotech company came under pressure after U.S. International Trade Commission staff issued a post-hearing brief backing a rival ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE